Patent litigation for adalimumab resolved in the US
AbbVie has announced that it has resolved its US HUMIRA…
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.
List view / Grid view
AbbVie has announced that it has resolved its US HUMIRA…
AbbVie has announced that it has resolved its US HUMIRA (adalimumab) litigation with Boehringer Ingelheim.